Search
for
Sort by
Research 181–210 of 1000+
- Histopathological Findings of Uncomplicated Hair Transplant for Male Androgenetic Alopecia: Can Lichen Planopilaris Features Be Present?
- Hair Number per Follicular Unit as a Marker of Treatment Response to Combined Autologous Scalp‐Derived Micrografts and Allogeneic SHED ‐ CM in Male Androgenetic Alopecia
- Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
- The Proportion of Catagen and Telogen Hair Follicles in Occipital Scalp of Male Androgenetic Alopecia Patients: Challenging the Established Dogma
- The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study
- Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial
- Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Efficacy and Safety of a Botanical Topical Serum on Male and Female Androgenetic Alopecia
- Dermoscopic pre‐ and posttreatment evaluation in patients with androgenetic alopecia on platelet‐rich plasma—A prospective study
- Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia
- Self-assembling peptide inspired by insulin and type 1 insulin-like growth factor for the treatment of androgenetic alopecia
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
- Efficacy of Dutasteride Intradermal Injection in The Treatment of Androgenetic Alopecia
- Giant Cells in Male Pattern Alopecia: a Histologic Marker and Pathogenetic Clue
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part II
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2
- The Roles of EDA2R in Ageing and Disease
- Psychosocial impact of androgenetic alopecia on men: A systematic review and meta-analysis
- Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors